Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Jun 01, 2016 $1.54 $1.55 $1.47 $1.52 309 046
May 31, 2016 $1.59 $1.59 $1.51 $1.53 130 967
May 27, 2016 $1.57 $1.63 $1.52 $1.56 116 697
May 26, 2016 $1.59 $1.69 $1.56 $1.57 96 289
May 25, 2016 $1.62 $1.67 $1.57 $1.59 115 355
May 24, 2016 $1.60 $1.64 $1.58 $1.61 74 664
May 23, 2016 $1.51 $1.66 $1.51 $1.57 169 041
May 20, 2016 $1.53 $1.57 $1.48 $1.51 130 822
May 19, 2016 $1.52 $1.64 $1.49 $1.49 96 313
May 18, 2016 $1.52 $1.61 $1.50 $1.52 138 268
May 17, 2016 $1.54 $1.55 $1.50 $1.52 103 948
May 16, 2016 $1.59 $1.59 $1.52 $1.54 108 996
May 13, 2016 $1.59 $1.62 $1.55 $1.59 105 673
May 12, 2016 $1.70 $1.73 $1.57 $1.59 211 136
May 11, 2016 $1.72 $1.75 $1.65 $1.69 38 829
May 10, 2016 $1.60 $1.73 $1.60 $1.72 46 424
May 09, 2016 $1.74 $1.75 $1.66 $1.73 68 511
May 06, 2016 $1.67 $1.76 $1.63 $1.71 102 161
May 05, 2016 $1.74 $1.77 $1.63 $1.69 103 405
May 04, 2016 $1.81 $1.87 $1.68 $1.74 209 569
May 03, 2016 $1.81 $1.86 $1.76 $1.81 252 321
May 02, 2016 $1.92 $1.92 $1.81 $1.86 166 701
Apr 29, 2016 $1.95 $2.00 $1.82 $1.90 140 565
Apr 28, 2016 $1.94 $2.02 $1.86 $1.96 165 235
Apr 27, 2016 $1.90 $1.97 $1.88 $1.93 90 310
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT